Difficult-to-Treat Asthma in Childhood

被引:0
|
作者
Alexandra Adams
Sejal Saglani
机构
[1] The Royal Brompton Hospital London and Imperial College London,Department of Respiratory Paediatrics
[2] National Heart and Lung Institute,undefined
[3] Faculty of Medicine,undefined
[4] Imperial College London,undefined
来源
Pediatric Drugs | 2013年 / 15卷
关键词
Asthma; Severe Asthma; Omalizumab; Primary Ciliary Dyskinesia; British Thoracic Society;
D O I
暂无
中图分类号
学科分类号
摘要
Asthma continues to be one of the greatest burdens to healthcare resources throughout the developed world. In most cases, good symptom control can be achieved with low-dose inhaled corticosteroids, and can be cared for in the primary and secondary healthcare systems. However, there is a group in whom control is not achieved despite high-dose inhaled corticosteroids and maximal add-on therapies; these are children with problematic severe asthma that should be referred to a specialist team for further investigation and management. In this review we aimed to provide an evidence-based guide for pediatricians providing care for children with asthma in secondary healthcare settings. The review focuses on a proposed investigation and management strategy for children aged between 6 and 16 years with problematic severe asthma, and is supported as far as possible by evidence from the literature. We first address recent advances in nomenclature and then discuss our proposed course of investigation and management of these children. Distinction of children with true, severe, therapy-resistant asthma from those with asthma that is difficult to treat because of unaddressed underlying modifiable factors is critical and is discussed in detail.
引用
收藏
页码:171 / 179
页数:8
相关论文
共 50 条
  • [1] Difficult-to-Treat Asthma in Childhood
    Adams, Alexandra
    Saglani, Sejal
    [J]. PEDIATRIC DRUGS, 2013, 15 (03) : 171 - 179
  • [2] Difficult-to-treat asthma, is it really difficult?
    Al-Hajjaj, Mohamed S.
    [J]. ANNALS OF THORACIC MEDICINE, 2011, 6 (01) : 1 - 2
  • [3] Systematic assessment of difficult-to-treat asthma
    Robinson, DS
    Campbell, DA
    Durharm, SR
    Pfeffer, J
    Barnes, PJ
    Chung, KF
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (03) : 478 - 483
  • [4] Targeted interventions for difficult-to-treat asthma
    Chipps, Bradley E.
    Harder, Julia M.
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (01) : 11 - 20
  • [5] Severe and Difficult-to-Treat Asthma in Adults
    Israel, Elliot
    Reddel, Helen K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (10): : 965 - 976
  • [6] Markers of Severity in Difficult-To-Treat Asthma
    Bush, Andrew
    [J]. PEDIATRIC PULMONOLOGY, 2017, 52 : S36 - S37
  • [7] Red plaques and difficult-to-treat asthma
    Wieshuber, Christine
    Wendel, Ana-Maria
    Trautmann, Axel
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2011, 9 (04): : 312 - 313
  • [8] Dupilumab utility in difficult-to-treat asthma
    Walsh, Garry M.
    [J]. IMMUNOTHERAPY, 2019, 11 (04) : 261 - 264
  • [9] Difficult-to-Treat and Severe Asthma: Management Strategies
    Narasimhan, Krishnan
    [J]. AMERICAN FAMILY PHYSICIAN, 2021, 103 (05) : 286 - 290
  • [10] Obstructive sleep apnea in difficult-to-treat asthma
    Guven, Firat S.
    Dursun, A.
    Kurt, Kar O.
    Ciftci, B.
    Erkekol, Oner F.
    [J]. ALLERGY, 2011, 66 : 363 - 364